Activating Compound | Comment | Organism | Structure |
---|---|---|---|
cAMP | required for PKA activity | Rattus norvegicus | |
forskolin | activates PKA | Rattus norvegicus | |
additional information | tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain | Rattus norvegicus |
Application | Comment | Organism |
---|---|---|
medicine | PKA and GSK-3 are targets for the therapeutic treatment of Alzheimer's disease and other tauopathies | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(Rp)-adenosine 3',5'-cyclic monophosphorothionate triethyl ammonium salt | inhibitor of PKA | Rattus norvegicus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
microtubule | - |
Rattus norvegicus | 5874 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | - |
Rattus norvegicus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [tau-protein] | Rattus norvegicus | abnormal hyperphosphorylation of tau by PKA and GSK-3 is associated with Alzheimer's disease and other tauopaties leading to neuronal degeneration | ADP + O-phospho-[tau-protein] | - |
? | |
additional information | Rattus norvegicus | tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain, inhibition of tau hyperphosphorylation inhibits an associated loss in spatial memory | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
ATP + [tau-protein] = ADP + O-phospho-[tau-protein] | GSK-3 and PKA catalyze tau phosphorylation in the brain, while GSK-3 performs phosphorylation of glycogen synthase, EC 2.7.11.1, and other proteins in different tissues, and PKA performs phosphorylation of other proteins in different tissues | Rattus norvegicus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Rattus norvegicus | - |
hippocampus | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [tau-protein] | abnormal hyperphosphorylation of tau by PKA and GSK-3 is associated with Alzheimer's disease and other tauopaties leading to neuronal degeneration | Rattus norvegicus | ADP + O-phospho-[tau-protein] | - |
? | |
ATP + [tau-protein] | phosphorylation by PKA at Ser214, and by GSK-3 at Ser404, Ser396, Ser198, Ser199, and Ser202 | Rattus norvegicus | ADP + O-phospho-[tau-protein] | - |
? | |
additional information | tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain, inhibition of tau hyperphosphorylation inhibits an associated loss in spatial memory | Rattus norvegicus | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
cAMP-dependent protein kinase A | - |
Rattus norvegicus |
glycogen synthase kinase-3 | - |
Rattus norvegicus |
GSK-3 | - |
Rattus norvegicus |
More | see also EC 2.7.11.1 and EC 2.7.11.11 | Rattus norvegicus |
PKA | - |
Rattus norvegicus |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
30 | - |
assay at | Rattus norvegicus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Rattus norvegicus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Rattus norvegicus |